Search Results for ""drugs for""
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for "drugs for". Results 2571 to 2580 of 2582 total matches.
Tattoo Removal
The Medical Letter on Drugs and Therapeutics • Nov 24, 2003 (Issue 1170)
95
The Medical Letter
®
On Drugs and Therapeutics
www.medicalletter.org
Published ...
While more people than ever are getting tattoos, many come to regret their decision and would like to have them removed. The technology of removing tattoos is much better than it used to be, but still far from perfect. Complete removal of all pigments with restoration of normal skin color and texture is not always possible (M Kuperman-Beade et al, Am J Clin Dermatol 2001; 2:21; GM Lipper and RR Anderson in IM Freedberg et al, eds, Fitzpatrick's Dermatology in General Medicine 6th ed, New York:McGraw-Hill 2003, page 2508).
A Mometasone-Eluting Sinus Implant (Sinuva) for Nasal Polyps
The Medical Letter on Drugs and Therapeutics • Sep 10, 2018 (Issue 1555)
with permission by First Databank,
Inc. All rights reserved. ©2018. www.fdbhealth.com/policies/
drug-pricing ...
The FDA has approved Sinuva (Intersect ENT), a sinus
implant that gradually releases the corticosteroid
mometasone furoate over a 90-day period, for
treatment of nasal polyps in adults who have had
ethmoid sinus surgery. Propel, a sinus implant that
releases mometasone furoate over 30 days, is FDA-approved
to maintain the sinus opening after ethmoid
sinus surgery; it is marketed by the same manufacturer
as Sinuva.
Treatment of Pressure Ulcers
The Medical Letter on Drugs and Therapeutics • Feb 23, 1990 (Issue 812)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Pressure is the most critical factor in the development of pressure ulcers; high pressure applied constantly for two hours produces irreversible tissue ischemia and necrosis. Malnutrition, fecal and urinary incontinence, fractures, and a low serum albumin may be additional risk factors. Frequent turning and mobilization of patients, relieving pressure and allowing tissue reoxygenation, are the most effective means of prevention and treatment (PS Goode and RM Allman, Med Clin North Am, 73:1511, Nov 1989).
Oat Bran for Lowering Blood Lipids
The Medical Letter on Drugs and Therapeutics • Dec 02, 1988 (Issue 780)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Oat bran, the ground inner husk of the grain, has recently become popular as a dietary means of lowering blood lipids. It is available both separately and as a constituent of oatmeal, which is the ground product of the whole grain. Oat bran and oatmeal are available in various breakfast cereals and can also be used in baked goods, such as muffins or bread. Some of these sources are listed in the table on page 112.
A Pneumococcal Conjugate Vaccine for Infants and Children
The Medical Letter on Drugs and Therapeutics • Mar 20, 2000 (Issue 1074)
The Medical Letter
On Drugs and Therapeutics
Published by The Medical Letter, Inc. • 1000 Main ...
The FDA has approved a conjugate heptavalent pneumococcal vaccine for prevention of invasive pneumococcal disease in infants and children.
Diagnostic Tests for HIV
The Medical Letter on Drugs and Therapeutics • Aug 29, 1997 (Issue 1008)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Diagnostic tests for human immunodeficiency virus (HIV) infection use four approaches: identification of antibodies to viral proteins, detection of viral antigens, detection of viral nucleic acids, and culturing the virus (CJ Schleupner in GL Mandell et al, eds, Principles and Practice of Infectious Diseases, 4th ed, New York:Churchill Livingstone, 1995, page 1253). In recent years, the FDA has approved the use of a 10- minute blood test, two home collection kits, and office tests that use urine and oral secretions to diagnose HIV infection. One home test, Confide (Johnson & Johnson), was...
New Glucose-monitoring Technologies
The Medical Letter on Drugs and Therapeutics • Dec 08, 2003 (Issue 1171)
The Medical Letter
®
On Drugs and Therapeutics
www.medicalletter.org
Published by The Medical Letter, Inc ...
Improved glucose meters and 2 sensing systems for continuous monitoring have become available for management of diabetes.
COVID-19 Update: Novavax Vaccine for 2024-2025
The Medical Letter on Drugs and Therapeutics • Oct 28, 2024 (Issue 1714)
formulations
for 2024-2025. Med Lett Drugs Ther 2024; 66:151.
4. COVID-19 Real-Time Learning Network. COVID ...
A 2024-2025 formulation of the Novavax adjuvanted
protein subunit COVID-19 vaccine that more
closely targets currently circulating SARS-CoV-2
variants is available now under an FDA Emergency
Use Authorization (EUA) for use in persons ≥12
years old. The 2024-2025 formulations of the
mRNA COVID-19 vaccines manufactured by Pfizer/BioNTech (Comirnaty) and Moderna (Spikevax) were licensed by the FDA last month for use in persons ≥12
years old and made available under EUAs for use in
persons 6 months to 11 years old.
Med Lett Drugs Ther. 2024 Oct 28;66(1714):175-6 doi:10.58347/tml.2024.1714d | Show Introduction Hide Introduction
Lasik and Its Alternatives: An Update
The Medical Letter on Drugs and Therapeutics • Jan 19, 2004 (Issue 1174)
to the cost ($500 to $2500 per eye) of conventional LASIK.
5
The Medical Letter
®
On Drugs ...
Since the last Medical Letter article on surgical correction of refractive errors (Volume 41, page 122, 1999), some new techniques have been tried and new results have been reported.
Cord Blood Banks
The Medical Letter on Drugs and Therapeutics • Oct 01, 2001 (Issue 1114)
The Medical Letter
On Drugs and Therapeutics
www.medletter.com
Published by The Medical ...
Pregnant women now often receive promotional material from private cord blood banks urging them to save and store their babies' cord blood.